Your browser is no longer supported. Please, upgrade your browser.
Settings
ADHD Alcobra Ltd. daily Stock Chart
ADHD [NASD]
Alcobra Ltd.
Index- P/E- EPS (ttm)-0.76 Insider Own32.83% Shs Outstand26.61M Perf Week15.98%
Market Cap33.79M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float21.87M Perf Month19.81%
Income-20.90M PEG- EPS next Q-0.38 Inst Own31.80% Short Float3.77% Perf Quarter11.40%
Sales- P/S- EPS this Y0.70% Inst Trans1.16% Short Ratio2.43 Perf Half Y11.40%
Book/sh1.48 P/B0.86 EPS next Y11.70% ROA-42.70% Target Price1.67 Perf Year-46.64%
Cash/sh1.55 P/C0.82 EPS next 5Y- ROE-45.30% 52W Range0.83 - 2.58 Perf YTD-39.52%
Dividend- P/FCF- EPS past 5Y-12.20% ROI- 52W High-40.25% Beta1.49
Dividend %- Quick Ratio25.40 Sales past 5Y- Gross Margin- 52W Low85.50% ATR0.10
Employees19 Current Ratio25.40 Sales Q/Q- Oper. Margin- RSI (14)81.46 Volatility18.50% 9.48%
OptionableYes Debt/Eq0.00 EPS Q/Q36.20% Profit Margin- Rel Volume100.77 Prev Close1.27
ShortableYes LT Debt/Eq0.00 EarningsNov 10 BMO Payout- Avg Volume339.83K Price1.54
Recom3.00 SMA2040.02% SMA5044.56% SMA20031.39% Volume32,074,183 Change21.26%
Sep-29-17Downgrade ROTH Capital Buy → Neutral
Jan-18-17Downgrade Jefferies Buy → Hold
Nov-02-16Upgrade WBB Securities Sell → Hold $4 → $1.90
Sep-30-16Downgrade Piper Jaffray Overweight → Neutral
Sep-29-16Downgrade Cantor Fitzgerald Buy → Hold
Sep-12-16Downgrade WBB Securities Hold → Sell $5 → $4
Aug-01-16Initiated Barclays Equal Weight $8
Jun-21-16Resumed ROTH Capital Buy
Jun-07-16Initiated Cantor Fitzgerald Buy $16
Feb-18-16Initiated Jefferies Buy
Jan-25-16Initiated Oppenheimer Outperform $16
Aug-14-15Reiterated ROTH Capital Buy $10 → $16
Jun-24-15Downgrade WBB Securities Speculative Buy → Hold $5
Nov-18-14Reiterated ROTH Capital Buy $30 → $10
Oct-23-14Downgrade FBR Capital Outperform → Mkt Perform $22 → $4
Oct-07-14Upgrade WBB Securities Hold → Speculative Buy $18 → $9
Oct-07-14Upgrade FBR Capital Mkt Perform → Outperform $23 → $22
Oct-06-14Reiterated ROTH Capital Buy $40 → $30
Aug-27-14Initiated FBR Capital Mkt Perform $23
Jun-26-14Initiated WBB Securities Hold $18
Oct-19-17 12:04PM  Alcobra Ltd (ADHD) Stock Fires Up To The Roof; Heres Why SmarterAnalyst +21.26%
07:00AM  Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines GlobeNewswire
Oct-06-17 08:00AM  Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference GlobeNewswire
Oct-05-17 08:25PM  Should You Be Concerned About Alcobra Ltds (ADHD) Risks? Simply Wall St.
Sep-27-17 06:19PM  Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge GlobeNewswire
Aug-11-17 11:09PM  Alcobra reports 2Q loss Associated Press
08:00AM  Alcobra Announces Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Jul-21-17 08:30AM  BioLine Rx (BLRX) Catches Eye: Stock Adds 5.2% in Session Zacks
Jul-20-17 10:46AM  New Strong Buy Stocks for July 20th Zacks
Jun-26-17 08:15AM  Featured Company News - Gilead's Vosevi Receives Positive Opinion from European CHMP; Set to Deliver Advanced Treatment for All HCV Genotypes Accesswire
Jun-23-17 07:00AM  Alcobra Updates on its Review of Strategic Alternatives GlobeNewswire
Jun-21-17 04:32AM  Shire wins U.S. approval for long-acting ADHD drug Reuters
Jun-20-17 07:19PM  Shire's long-acting ADHD drug wins U.S. approval Reuters
Jun-12-17 08:36AM  Alcobra Announces Cooperation Agreement with Brosh Group and Board Additions GlobeNewswire
May-31-17 12:01AM  Swiss biotech NLS Pharma's ADHD drug succeeds in mid-stage study Reuters
May-30-17 08:31AM  Alcobra reports 1Q loss Associated Press
08:00AM  Alcobra Announces First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
May-16-17 03:34PM  Chuck Royce Continues to Buy These 10 Stocks GuruFocus.com
May-15-17 08:00AM  Alcobra Announces Leadership Update GlobeNewswire
May-05-17 12:43PM  Alcobra Provides Update on Cancellation of Extraordinary Meeting Called by Brosh Group GlobeNewswire
Apr-24-17 06:00AM  Alcobra Mails Proxy Materials for Extraordinary General Meeting of Shareholders GlobeNewswire +7.27%
Apr-12-17 09:05AM  Exodus Capital is Summoning an Extraordinary General Meeting PR Newswire
Apr-07-17 07:30AM  Tenax Therapeutics and Alcobra Find Rough Waters Ahead Accesswire -8.20%
Apr-05-17 08:00AM  Alcobra Provides Update on Request for Extraordinary General Meeting GlobeNewswire
08:00AM  Alcobra Provides Update on Request for Extraordinary General Meeting
Mar-28-17 10:21AM  SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Alcobra Ltd. Business Wire
Mar-27-17 09:15PM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm Business Wire
Mar-17-17 11:29PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Business Wire -6.56%
Mar-16-17 12:35PM  Brosh Capital Delivers Extraordinary General Meeting Request To Alcobra And Issues Letter To Chairman PR Newswire
Mar-15-17 11:53AM  IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-14-17 04:50PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
Mar-09-17 11:31AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-08-17 06:10PM  SHAREHOLDER ALERT: SFMS Announces Filing of Securities Class Action Lawsuit Against Alcobra, Ltd. GlobeNewswire
Mar-07-17 08:00AM  Alcobra Ltd. to Participate in Upcoming Healthcare Conferences GlobeNewswire
Mar-03-17 10:20AM  INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-01-17 09:00AM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
08:00AM  Alcobra to Host Investor Forum and Webcast on March 28 in New York City GlobeNewswire
Feb-24-17 08:04PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Accesswire
06:00PM  IMPORTANT ALCOBRA LTD. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the Southern District of New York on behalf of purchasers of Alcobra Ltd. GlobeNewswire
11:04AM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire
10:30AM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm Business Wire
Feb-23-17 06:26PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Accesswire
04:51PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Alcobra Ltd. Investors and Encourages Investors to Contact the Firm Business Wire
11:02AM  INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
Feb-22-17 10:10PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. (ADHD) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
Feb-17-17 06:43PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alcobra, Ltd., and Encourages Investors with Losses to Contact the Firm Business Wire
05:11PM  Lifshitz & Miller LLP Files Class Action Lawsuit against Alcobra, Ltd. PR Newswire
08:15AM  Blog Coverage Ardelyx Reports Positive Data for the Treatment for Hyperphosphatemia in Patients with End-Stage Renal disease Accesswire
Feb-15-17 12:06PM  Edited Transcript of ADHD earnings conference call or presentation 15-Feb-17 1:30pm GMT +8.33%
07:26AM  Alcobra reports 4Q loss
07:07AM  Q4 2016 Alcobra Ltd Earnings Release - 08:30 am ET
07:00AM  Alcobra Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Corporate Update GlobeNewswire
Feb-08-17 08:00AM  Alcobra Ltd. to Release Fiscal 2016 Financial Results and Participate at the BIO CEO & Investor Conference in New York GlobeNewswire
Feb-06-17 04:01PM  Alcobra Reports on Productive FDA Meeting for New Lead Product Candidate for ADHD GlobeNewswire
Feb-03-17 08:43AM  Are Options Traders Betting on a Big Move in Alcobra (ADHD) Stock? +17.24%
Feb-02-17 03:52PM  INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm Accesswire -8.66%
01:42PM  Lifshitz & Miller Law Firm Announces Investigation of Alcobra Ltd., Egalet Corporation, Sanderson Farms, Inc., Surgical Care Affiliates, Inc., State Street Corporation, Tenet Healthcare Corp., Vista Outdoor Inc. and Zagg Inc. PR Newswire
09:45AM  Faster FDA Approval Process Could Ignite These Biotech Stocks in 2017 Accesswire
Jan-31-17 11:25AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Alcobra, Ltd., and Encourages Investors to Contact the Firm Business Wire
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alcobra Ltd. Investors Business Wire
Jan-20-17 05:50PM  Shire's (SHPG) ADHD Candidate's NDA Accepted by FDA
10:12AM  Alcobra Leads Biotech Movers Early Friday
Jan-19-17 11:05AM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Alcobra, Ltd. and Encourages Investors with Losses to Contact the Firm Business Wire
Jan-18-17 03:03PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Alcobra Ltd. Business Wire +9.88%
12:37PM  Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug
10:50AM  Alcobra Ltd (ADHD): Heres Our Take at Insider Monkey
08:55AM  Alcobra Stock Plunges 50% on Failed ADHD Drug at Investopedia
06:52AM  Alcobra Pharma downgraded by Jefferies
Jan-17-17 08:36PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Alcobra, Ltd. and Advises Investors with Losses to Contact the Firm Business Wire -50.66%
05:39PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Alcobra Ltd. Investors Business Wire
04:31PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alcobra Ltd. (ADHD) PR Newswire
04:05PM  DryShips, Alcobra Sink into Tuesdays 52-Week Low Club
03:57PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alcobra Ltd. - ADHD PR Newswire
12:42PM  Alcobra Shares Plummet as ADHD Drug Fails
11:05AM  Tuesdays Top Biopharma Movers
09:19AM  Alcobra to stop testing sole drug for ADHD after study fails
08:19AM  Alcobra Ltd. stock plummets 43% after failed late-stage trial for its ADHD drug at MarketWatch
07:16AM  Alcobra's ADHD drug fails late-stage study
07:00AM  Alcobra Reports Phase 3 Clinical Trial of MDX in Adults with ADHD Missed Primary Endpoint GlobeNewswire
Jan-09-17 09:50AM  Mondays 4 Biggest Biopharma Movers -13.89%
07:00AM  Alcobra Provides Update on Recent FDA Meeting and Path Forward for MDX Clinical Development Program GlobeNewswire
Dec-23-16 08:15AM  Post Earnings Coverage as Arrowhead Reported Annual Results; Announced Collaboration with Amgen Accesswire
Dec-14-16 08:00AM  Alcobra Updates on Recent FDA Meeting GlobeNewswire
Dec-10-16 06:11PM  Is Alcobra Ltd (ADHD) Worthy of Your Portfolio? at Insider Monkey
Dec-06-16 10:12AM  Alcobra Ltd. :ADHD-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016
Nov-15-16 12:14PM  Edited Transcript of ADHD earnings conference call or presentation 15-Nov-16 1:30pm GMT -5.13%
07:40AM  Alcobra reports 3Q loss
07:30AM  Alcobra Announces Third Quarter 2016 Financial Results and Provides Corporate Update GlobeNewswire
07:07AM  Q3 2016 Alcobra Ltd Earnings Release - Before Market Open
06:55AM  Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
Nov-07-16 08:00AM  Alcobra Ltd. to Participate in Upcoming Healthcare Conferences GlobeNewswire
Nov-01-16 08:32AM  Jazz Pharma (JAZZ) Q3 Earnings: A Disappointment in Store?
08:00AM  Alcobra Ltd. to Release Third Quarter Financial Results and Host Corporate Update Conference Call & Webcast on November 15 GlobeNewswire
Oct-23-16 06:19PM  RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold at Insider Monkey
Oct-07-16 08:48AM  Update from Alcobra on Recent FDA Communications GlobeNewswire
Oct-02-16 10:10AM  5 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Sep-30-16 01:39PM  [video]Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold
Sep-29-16 12:46PM  Heres Why These Five Stocks Are in the Spotlight Today at Insider Monkey -45.67%
12:05PM  Alcobra Tumbles on FDA Clinical Hold
10:12AM  Alcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary pharmaceutical products. The company' s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Alcobra Ltd. was founded in 2008 and is headquartered in Tel Aviv, Israel.